176 related articles for article (PubMed ID: 3909374)
1. Ulcer healing and relapse prevention by ranitidine in peptic ulcer disease.
Liedberg G; Davies HJ; Enskog L; Eriksson S; Frederiksen B; Graffner H; Hradsky M; Oscarson J; Rydberg B; Simert G
Scand J Gastroenterol; 1985 Oct; 20(8):941-4. PubMed ID: 3909374
[TBL] [Abstract][Full Text] [Related]
2. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.
Farley A; Lévesque D; Paré P; Thomson AB; Sherbaniuk R; Archambault A; Mahoney K
Am J Gastroenterol; 1985 Sep; 80(9):665-8. PubMed ID: 3898818
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trial.
Lauritsen K; Bytzer P; Hansen J; Bekker C; Rask-Madsen J
Scand J Gastroenterol; 1985 Jan; 20(1):123-8. PubMed ID: 3887547
[TBL] [Abstract][Full Text] [Related]
5. Are endoscopic and/or histologic findings in gastroduodenal mucosa a predictor of clinical outcome in peptic ulcer disease? A 1-year follow-up study after initial healing with either cimetidine or medium-dose antacid.
Jönsson KA; Bodemar G; Norrby K; Walan A; Tysk C
Scand J Gastroenterol; 1988 Mar; 23(2):199-208. PubMed ID: 3283917
[TBL] [Abstract][Full Text] [Related]
6. A comparison of 4-week peptic ulcer healing rates following treatment with antacids and ranitidine.
Bezuidenhout DJ; Perold JG; Adams G
S Afr Med J; 1984 Jun; 65(25):1007-9. PubMed ID: 6328685
[TBL] [Abstract][Full Text] [Related]
7. Antacids in the treatment of duodenal ulcer.
Lublin H; Amiri S; Jensen HE
Acta Med Scand; 1985; 217(1):111-6. PubMed ID: 3883700
[TBL] [Abstract][Full Text] [Related]
8. Ranitidine 150 mg at night in the prevention of gastric ulcer relapse.
Jorde R; Burhol PG; Hansen T
Gut; 1987 Apr; 28(4):460-3. PubMed ID: 3556338
[TBL] [Abstract][Full Text] [Related]
9. Review of peptic ulcer maintenance trials.
Robinson M
Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine in the treatment of peptic ulcer.
Makalinao AU; Zaño FM
Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
[TBL] [Abstract][Full Text] [Related]
11. Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.
Forssell H; Koch G
Eur J Clin Pharmacol; 1983; 25(2):195-8. PubMed ID: 6313376
[TBL] [Abstract][Full Text] [Related]
12. Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
Gut; 1990 Jun; 31(6):653-6. PubMed ID: 2199347
[TBL] [Abstract][Full Text] [Related]
13. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
Simon B; Cremer M; Dammann HG; Hentschel E; Keohane PP; Mulder H; Müller P; Sarles H
Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257
[TBL] [Abstract][Full Text] [Related]
14. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
Bories P; Tournade JM; Alberola B; Pappo M
Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
[TBL] [Abstract][Full Text] [Related]
15. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
Walan A; Bader JP; Classen M; Lamers CB; Piper DW; Rutgersson K; Eriksson S
N Engl J Med; 1989 Jan; 320(2):69-75. PubMed ID: 2643037
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine in the maintenance therapy of gastro-duodenal ulcer disease: Polish open multicentre study.
Gibiński K; Nowak A; Gabryelewicz A; Szałaj W; Hasik J; Klincewicz H; Butruk E; Kosecki P; Pokora J; Radwan P
Hepatogastroenterology; 1984 Aug; 31(4):180-2. PubMed ID: 6090287
[TBL] [Abstract][Full Text] [Related]
17. Duodenal and gastric ulcer healing rates: a review.
Legerton CW
Am J Med; 1984 Nov; 77(5B):2-7. PubMed ID: 6095656
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine versus anticholinergic/antacid for duodenal ulcer. A randomized, endoscopically controlled, single-blind multicentre trial.
Miettinen P; Anttonen V; Aukee S; Huttunen R; Lahtinen J; Poikolainen E; Pääkkönen M; Tammela T
Scand J Gastroenterol; 1985 Aug; 20(6):701-5. PubMed ID: 3898348
[TBL] [Abstract][Full Text] [Related]
19. Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs.
Tildesley G; Ehsanullah RS; Wood JR
Br J Rheumatol; 1993 Jun; 32(6):474-8. PubMed ID: 8508283
[TBL] [Abstract][Full Text] [Related]
20. [Ranitidine therapy of duodenal ulcer: comparison of once-a-day and twice-a-day administration. A Swiss multicenter double-blind study].
Aenishänslin W; Bergoz R; Capitaine Y; Egger G; Etienne A; Fumagalli I; Güller R; Hammer B; Kobler E; Leuthold E
Schweiz Med Wochenschr; 1986 May; 116(19):637-41. PubMed ID: 3715441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
